Michel Hubert, PharmD

Versailles, France
Michel HUBERT has more than 25 years of experience in Corporate and Business Development and an impressive track record of deal making. He worked for major and mid-size pharmaceutical and biotech companies such as Abbott Laboratories, Solvay Pharmaceuticals, Novartis, Transgene, Laboratoires Fournier and Rhône-Poulenc (now Sanofi). Michel HUBERT was instrumental in deals such as the acquisition of DNA Therapeutics by Onxeo, Abbott Fournier Tricor license agreement and related fenofibrate novel formulation deals, Roche Transgene HPV vaccine licensing agreement, Novartis MGH MIT Huntington Disease R&D agreement. Michel HUBERT is a graduate from Strasbourg School of Pharmacy and holds a MS in International Business from St Mary’s College of California. Michel HUBERT is the former treasurer of the Pharma Licensing Club France - PLCF
Speaking In
2:45 PM - 3:00 PM
Monday, June 5
Oxymo Technologies, a French-Canadian biotech, is developing Oximo, a topical drug product for the…
Session Room 104B